Erratum: Sef Is an Inhibitor of Proinflammatory Cytokine Signaling, Acting by Cytoplasmic Sequestration of NF-κB (Sef Is an Inhibitor of Proinflammatory Cytokine Signaling, Acting by Cytoplasmic Sequestration of NF-κB (2012) 23(3) (611–623), (S1534580712003322), (10.1016/j.devcel.2012.07.013));Sef Is an Inhibitor of Proinflammatory Cytokine Signaling, Acting by Cytoplasmic Sequestration of NF-κB

Developmental Cell

Volumn 23, Issue 3, 2012, Pages 611-623

  Fuchs, Yaron ^a   Brunwasser, Michal ^a   Haif, Sasha ^a   Haddad, Jumana ^a   Shneyer, Boris ^a   Goldshmidt Tran, Orit ^a   Korsensky, Lina ^a   Abed, Mona ^a   Zisman Rozen, Simona ^a   Koren, Lilach ^a   Carmi, Yaron ^b   Apte, Ron ^b   Yang, Ruey Bing ^c   Orian, Amir ^a   Bejar, Jacob ^d   Ron, Dina ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PROTEIN SEF; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 84866029214     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2020.10.022     Document Type: Erratum

References (47)

1. Basak S., Kim H., Kearns J.D., Tergaonkar V., O'Dea E., Werner S.L., Benedict C.A., Ware C.F., Ghosh G., Verma I.M., Hoffmann A. A fourth IkappaB protein within the NF-kappaB signaling module. Cell 2007, 128:369-381.
2. Bassères D.S., Baldwin A.S. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006, 25:6817-6830.
3. Cao Z., Henzel W.J., Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996, 271:1128-1131.
4. Crosby L.M., Waters C.M. Epithelial repair mechanisms in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 298:L715-L731.
5. Dinarello C.A. Proinflammatory cytokines. Chest 2000, 118:503-508.
6. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
7. Fagerlund R., Kinnunen L., Köhler M., Julkunen I., Melén K. NF-kappaB is transported into the nucleus by importin alpha3 and importin alpha4. J. Biol. Chem. 2005, 280:15942-15951.
8. Ferreiro D.U., Komives E.A. Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha. Biochemistry 2010, 49:1560-1567.
9. Freeman M. Feedback control of intercellular signalling in development. Nature 2000, 408:313-319.
10. Fürthauer M., Lin W., Ang S.L., Thisse B., Thisse C. Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling. Nat. Cell Biol. 2002, 4:170-174.
11. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl):S81-S96.
12. Grothe C., Claus P., Haastert K., Lutwak E., Ron D. Expression and regulation of Sef, a novel signaling inhibitor of receptor tyrosine kinases-mediated signaling in the nervous system. Acta Histochem. 2008, 110:155-162.
13. Häcker H., Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, 2006:re13.
14. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
15. Heilker R., Freuler F., Pulfer R., Di Padova F., Eder J. All three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complex. Eur. J. Biochem. 1999, 259:253-261.
16. Hoffmann A., Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 2006, 210:171-186.
17. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002, 298:1241-1245.
18. Horai R., Asano M., Sudo K., Kanuka H., Suzuki M., Nishihara M., Takahashi M., Iwakura Y. Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 1998, 187:1463-1475.
19. Kasowski M., Grubert F., Heffelfinger C., Hariharan M., Asabere A., Waszak S.M., Habegger L., Rozowsky J., Shi M., Urban A.E., et al. Variation in transcription factor binding among humans. Science 2010, 328:232-235.
20. Kovalenko D., Yang X., Nadeau R.J., Harkins L.K., Friesel R. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation. J. Biol. Chem. 2003, 278:14087-14091.
21. Maas-Szabowski N., Stark H.J., Fusenig N.E. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J. Invest. Dermatol. 2000, 114:1075-1084.
22. Murphy T., Darby S., Mathers M.E., Gnanapragasam V.J. Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype. J. Pathol. 2010, 220:452-460.
23. Natoli G., Chiocca S. Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation. Sci. Signal. 2008, 1:pe1.
24. Naugler W.E., Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr. Opin. Genet. Dev. 2008, 18:19-26.
25. Niehrs C., Meinhardt H. Modular feedback. Nature 2002, 417:35-36.
26. Niu J., Chang Z., Peng B., Xia Q., Lu W., Huang P., Tsao M.S., Chiao P.J. Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappaB transcription factors. J. Biol. Chem. 2007, 282:6001-6011.
27. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 2009, 9:778-788.
28. Pawson T., Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 2003, 300:445-452.
29. Preger E., Ziv I., Shabtay A., Sher I., Tsang M., Dawid I.B., Altuvia Y., Ron D. Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity. Proc. Natl. Acad. Sci. USA 2004, 101:1229-1234.
30. Presta M., Andrés G., Leali D., Dell'Era P., Ronca R. Inflammatory cells and chemokines sustain FGF2-induced angiogenesis. Eur. Cytokine Netw. 2009, 20:39-50.
31. Reich-Slotky R., Shaoul E., Berman B., Graziani G., Ron D. Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificities. J. Biol. Chem. 1995, 270:29813-29818.
32. Ren Y., Li Z., Rong Z., Cheng L., Li Y., Wang Z., Chang Z. Tyrosine 330 in hSef is critical for the localization and the inhibitory effect on FGF signaling. Biochem. Biophys. Res. Commun. 2007, 354:741-746.
33. Ron D., Fuchs Y., Chorev D.S. Know thy Sef: a novel class of feedback antagonists of receptor tyrosine kinase signaling. Int. J. Biochem. Cell Biol. 2008, 40:2040-2052.
34. Simon M.A. Receptor tyrosine kinases: specific outcomes from general signals. Cell 2000, 103:13-15.
35. Tang T., Li L., Tang J., Li Y., Lin W.Y., Martin F., Grant D., Solloway M., Parker L., Ye W., et al. A mouse knockout library for secreted and transmembrane proteins. Nat. Biotechnol. 2010, 28:749-755.
36. Thompson J.E., Phillips R.J., Erdjument-Bromage H., Tempst P., Ghosh S. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 1995, 80:573-582.
37. Torii S., Kusakabe M., Yamamoto T., Maekawa M., Nishida E. Sef is a spatial regulator for Ras/MAP kinase signaling. Dev. Cell 2004, 7:33-44.
38. Tsang M., Friesel R., Kudoh T., Dawid I.B. Identification of Sef, a novel modulator of FGF signalling. Nat. Cell Biol. 2002, 4:165-169.
39. Vandermoere F., El Yazidi-Belkoura I., Adriaenssens E., Lemoine J., Hondermarck H. The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Oncogene 2005, 24:5482-5491.
40. Verstrepen L., Bekaert T., Chau T.L., Tavernier J., Chariot A., Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell. Mol. Life Sci. 2008, 65:2964-2978.
41. Werner S., Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol. 2001, 11:143-146.
42. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83:835-870.
43. Xiong S., Zhao Q., Rong Z., Huang G., Huang Y., Chen P., Zhang S., Liu L., Chang Z. hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling. J. Biol. Chem. 2003, 278:50273-50282.
44. Yang R.B., Ng C.K., Wasserman S.M., Kömüves L.G., Gerritsen M.E., Topper J.N. A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling. J. Biol. Chem. 2003, 278:33232-33238.
45. Yang X., Kovalenko D., Nadeau R.J., Harkins L.K., Mitchell J., Zubanova O., Chen P.Y., Friesel R. Sef interacts with TAK1 and mediates JNK activation and apoptosis. J. Biol. Chem. 2004, 279:38099-38102.
46. Zisman-Rozen S., Fink D., Ben-Izhak O., Fuchs Y., Brodski A., Kraus M.H., Bejar J., Ron D. Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas. Oncogene 2007, 26:6093-6098.
47. Ziv I., Fuchs Y., Preger E., Shabtay A., Harduf H., Zilpa T., Dym N., Ron D. The human sef-a isoform utilizes different mechanisms to regulate receptor tyrosine kinase signaling pathways and subsequent cell fate. J. Biol. Chem. 2006, 281:39225-39235.